Zentalis Pharmaceuticals (ZNTL) - Trade Stocks

Zentalis Pharmaceuticals (ZNTL)

By Fri, Oct 15, 2021

Today’s Chart of the Week comes from our 2 to 100 Club Report.

This scanner specifically looks for small to midcap stocks poised to become the next $100 billion company.

And when it comes to that, pharmaceuticals are always a good place to look.

That’s why we’re long on Zentalis Pharmaceuticals (ZNTL).

Zentalis is a midcap stock valued around $6 billion that is poised for a nice gain.

There’s a major base we’ve broken out of, and as I like to say, the “bigger the base, the higher in space.”

There’s a nice uptrend here, with a phenomenal risk to reward ratio.

We are long ZNTL above 80 with a target of 113.

Til next week, good trading,

JC Parets

Sponsored Ad

Free Training: 60-Minutes to Trading Freedom

Would you like to make more money in one hour of fun trading than working all day at a job?

Then check this out…

Click here to reserve one of the limited spots!

About the Author

JC Parets, founder of All Star Charts, specializes in finding the most opportunistic risk vs. reward propositions while at the same time bringing a top/down approach to the marketplace whose wide spectrum is rivaled by few. JC begins with a long-term global macro perspective and then works his way down to the individual sector and industry level before ultimately isolating the stocks that best portray a particular thesis. Price is the most important technical indicator, but JC uses supplements such as Momentum, Relative Strength, and Fibonacci analysis to complete the process.